Haj Ola, Lipkin Miri, Kopylov Uri, Sigalit Sina, Magnezi Racheli
IBD Clinic, Gastroenterology Department, Sheba Medical Center, Derech Sheba 2, Ramat Gan 52621 Israel.
Department of Management, Health Systems Management, Bar Ilan University, Ramat Gan, Israel.
Therap Adv Gastroenterol. 2022 Oct 6;15:17562848221128757. doi: 10.1177/17562848221128757. eCollection 2022.
Patient activation refers to patients' independence in daily activities, involvement in the therapeutic process, and ability to manage their health. This study examined the association between the activation of patients with inflammatory bowel disease (IBD) and its effect on health indices.
To evaluate the association between the activation of patients with IBD measured by patient activation measure (PAM-13) questionnaire with disease activity and quality of life in IBD.
A retrospective cross-sectional study.
This study included patients with Crohn's Disease (CD) or ulcerative colitis (UC) followed at a large medical center in Israel, who were recruited during routine visits. They answered weekly questionnaires using a mobile smartphone application that included clinical and emotional disease parameters, including IBD control, quality of life [short IBD quality of life questionnaire (SIBDQ)], patient-reported outcomes measurement information system (PROMIS-10) and PAM-13. Additional clinical parameters were collected from electronic medical records.
Among 201 patients (113 females) who responded to the questionnaires, 152 (75.6%) had CD and 49 (24.4%) UC. For PAM-13, 158 (79%) patients were at PAM-13 levels 3-4 (mean score: 68.5, range: 60.0-73.1) and 43 (21%) were at levels 1-2 (mean score: 45.2, range: 40.9-49.9). PAM-13 levels were correlated with IBD control ( = 0.19, = 0.023), SIBDQ ( = 0.20, = 0.010), and PROMIS-10 score ( = 0.24, = 0.017).
Our findings demonstrate the importance of patient activation and engagement in IBD. Knowledge of patient activation may enable caregivers to predict levels of self-care and the likelihood of compliance with health behavior recommendations.
患者激活是指患者在日常活动中的独立性、参与治疗过程的程度以及管理自身健康的能力。本研究探讨了炎症性肠病（IBD）患者的激活与其对健康指标的影响之间的关联。
评估通过患者激活度量表（PAM-13）问卷测量的IBD患者激活与IBD疾病活动度及生活质量之间的关联。
一项回顾性横断面研究。
本研究纳入了在以色列一家大型医疗中心接受随访的克罗恩病（CD）或溃疡性结肠炎（UC）患者，这些患者是在常规就诊期间招募的。他们使用一款移动智能手机应用程序每周回答问卷，问卷包括临床和情绪方面的疾病参数，包括IBD控制情况、生活质量[IBD生活质量简短问卷（SIBDQ）]、患者报告结局测量信息系统（PROMIS-10）和PAM-13。从电子病历中收集其他临床参数。
在201名回复问卷的患者（113名女性）中，152名（75.6%）患有CD，49名（24.4%）患有UC。对于PAM-13，158名（79%）患者处于PAM-13的3-4级（平均得分：68.5，范围：60.0-73.1），43名（21%）处于1-2级（平均得分：45.2，范围：40.9-49.9）。PAM-13级别与IBD控制情况（r = 0.19，P = 0.023）、SIBDQ（r = 0.20，P = 0.010）和PROMIS-10得分（r = 0.24，P = 0.017）相关。
我们的研究结果表明患者激活和参与在IBD中的重要性。了解患者激活情况可能使护理人员能够预测自我护理水平以及遵守健康行为建议的可能性。
